stockportfolio.pro
Stocks / NGNE vs VREX
NGNE vs VREX
Neurogene Inc. and Varex Imaging Corporation side by side — fundamentals from SEC filings, refreshed nightly. Sector: Healthcare.
| Neurogene Inc. (NGNE) | Varex Imaging Corporation (VREX) | |
|---|---|---|
| Market cap | $0.5B | $0.4B |
| Revenue (latest FY) | $0 | $844.60M |
| Net income (latest FY) | $-90.35M | $-70.30M |
| Revenue growth (5y CAGR) | — | 2.7% |
| Net margin | — | -8.3% |
| Return on equity | -34.1% | -14.9% |
| P/E ratio | — | — |
| Dividend yield | — | — |
| Profitable years (of last 10) | 0 | 7 |
| Positive free cash flow | No | Yes |
Compare them properly — statement by statement
Open either company interactively: 19 years of income statement, balance sheet and cash flow, ratios, health checks, and Ask — the SEC-grounded research assistant.
Open NGNE — free Open VREX — freeFrequently asked questions
Which is bigger, NGNE or VREX?
Neurogene Inc. is larger by market capitalization — $0.5B versus $0.4B.
Which grows faster, NGNE or VREX?
Five-year growth data is not available for both companies.
Where does this data come from?
All figures are computed from official SEC filings (10-K), refreshed nightly. This is a data comparison, not investment advice.